Identification of the human plasma protein which inhibits fibrinolysis associated with malignant cells.
D000818:Animals; D001798:Blood Proteins / Q000494:pharmacology*; D002364:Caseins / Q000494:pharmacology; D002472:Cell Transformation, Viral; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis / Q000187:drug effects*; D005347:Fibroblasts / Q000378:metabolism*; D017988:Gammaretrovirus; D006801:Humans; D008545:Melanoma / Q000378:metabolism; D010958:Plasminogen / Q000378:metabolism; D010960:Plasminogen Activators / Q000378:metabolism; D009053:Sarcoma Viruses, Murine; D012513:Sarcoma, Experimental; D014359:Trypsin Inhibitor, Kazal Pancreatic / Q000494:pharmacology; D014568:Urokinase-Type Plasminogen Activator / Q000494:pharmacology
D001798:Blood Proteins; D002364:Caseins; D014359:Trypsin Inhibitor, Kazal Pancreatic; D010958:Plasminogen; D010960:Plasminogen Activators; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator